F-star Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2016 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
F-star Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2016 to 2021.
  • F-star Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000.
  • F-star Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$372K, a 37100% decline from 2020.
  • F-star Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was -$1K, a 99.9% increase from 2019.
  • F-star Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2019 was -$737K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$372K -$371K -37100% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-15
2020 -$1K +$736K +99.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$737K -$737K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2019-03-11
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2018-02-20
2016 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.